Home/Filings/4/0001209191-21-038972
4//SEC Filing

Priar Robert J 4

Accession 0001209191-21-038972

CIK 0001411690other

Filed

Jun 7, 8:00 PM ET

Accepted

Jun 8, 5:03 PM ET

Size

5.9 KB

Accession

0001209191-21-038972

Insider Transaction Report

Form 4
Period: 2021-06-01
Priar Robert J
Chief Commercial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-06-01+400,000400,000 total
    Exercise: $6.32Exp: 2031-06-01Common Stock (400,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option shall vest and become exercisable on June 1, 2022, and the remaining shares shall vest in a series of 36 successive equal monthly installments measured from June 1, 2022, subject to Reporting Person's Continuous Service (as defined in the Company's 2018 Equity Incentive Plan) through each such applicable vesting date and the terms of the Company's 2018 Equity Incentive Plan.

Issuer

Bionano Genomics, Inc

CIK 0001411690

Entity typeother

Related Parties

1
  • filerCIK 0001864620

Filing Metadata

Form type
4
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 5:03 PM ET
Size
5.9 KB